Milan, Italy — Global Access International On-Site Regenerative Treatment Program
- Dr. Andrew Peskau
- Jan 3, 2025
- 2 min read
Location: Milan, Italy
Program: Global Access — On-Site Regenerative Treatment
Patient: Adult patient (identity undisclosed)
Diagnosis: Parkinson’s disease (mid-stage)
Overview
As part of the Global Access program, the BioCells Medical medical team traveled to Milan, Italy, to deliver an individualized regenerative treatment protocol directly at the patient’s location.
This format is designed for patients who require advanced medical support but prefer or require treatment outside a clinical inpatient setting.
Medical Rationale
Parkinson’s disease is a progressive neurodegenerative condition associated with dopaminergic neuron dysfunction, neuroinflammation, and impaired neuromotor signaling.
The objective of this intervention was to support neurological function, reduce inflammatory burden, and stabilize functional performance through a science-based regenerative approach under medical supervision.
Treatment Protocol (Personalized)
Based on pre-treatment medical evaluation and clinical documentation, the protocol included:
Mesenchymal Stem Cell therapy (MSC) Focused on immunomodulation and neuro-supportive mechanisms relevant to neurodegenerative processes.
T-regulatory therapy Applied to support immune balance and reduce chronic neuroinflammatory activity.
Concentrated purified exosomes Used as a supportive regenerative component aligned with intercellular communication and tissue-support signaling pathways.
Targeted peptide therapy Selected peptides aimed at supporting neuronal metabolism and functional signaling.
Supportive neurofunctional therapy Integrated to support neuromuscular coordination and central nervous system adaptation.
Neurostimulation was not included in this protocol, as it was not clinically indicated for this specific patient profile.
Treatment Delivery
All procedures were performed by BioCells Medical specialists in accordance with internal clinical protocols and international medical standards.
The treatment session was completed successfully, without complications.
Post-Treatment Monitoring & Rehabilitation
Following the intervention:
A dedicated rehabilitation specialist has been assigned to the patient
Structured follow-up monitoring has been initiated
Clinical observations and progress indicators are being systematically documented
The patient remains under continuous medical supervision during the follow-up phase.
Global Access Program — BioCells Medical
The Global Access model enables BioCells Medical to deliver advanced regenerative therapies internationally by combining:
Mobile medical teams
In-house certified laboratory processing
Diagnosis-driven, individually adjusted treatment protocols
This approach ensures continuity of care while respecting patient-specific medical and logistical requirements.
Request a Medical Consultation
BioCells Medical provides international on-site regenerative treatment through its Global Access program.
During the consultation, our medical team reviews your medical records, diagnosis, and clinical history to determine whether Global Access is medically appropriate for your case and whether a personalized treatment protocol can be formulated.
